Dermatology

Your Article Summary

See Latest Articles

Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: Results of a German national survey
Journal of the European Academy of Dermatology and Venereology, 06/03/09

Radtke MA et al. - Data imply that there is still a significant number of patients suspected of having joint involvement without ever having been diagnosed with psoriatic arthritis (PsA). Joint damage and functional disability in these pts can be prevented if adequate treatment is started promptly.

• Study to determine the prevalence and clinical features of PsA and joint complaints in pts with psoriasis
• 2009 pts; pts showing rheumatological symptoms were further recorded with respect to active arthritis and PsA symptoms

• 19% of the pts had PsA, including 14.8% previously confirmed and 4.2% newly diagnosed disease
• Another 7.7% had intermittent but clinically unspecific joint symptoms, which could not be clearly attributed to PsA
• 49.7% of the pts with PsA had at least 1 swollen joint and 84.9% suffered from joint pain
• Pts suffering from pain marked an average of 8.7 joints on a diagram as painful out of a possible 28
• Mean number of swollen joints among the affected pts amounted to an average of 6.8

Related Articles

See all related articles

Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09    Relevance Score: 95%

FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09    Relevance Score: 91%

Study shows major burden of psoriasis
Internet Source, 10/29/09    Relevance Score: 91%

Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09    Relevance Score: 91%

Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09    Relevance Score: 91%

Today in Psoriasis...keeping you current

Receive free subspecialty "5-minute updates" via email

Development and validation of nail psoriasis quality of life scale (NPQ10)
Journal of the European Academy of Dermatology and Venereology, 12/16/09

Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09

Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09

 See all of Psoriasis